The Basics of Diversity‐Oriented Synthesis
暂无分享,去创建一个
Warren R. J. D. Galloway | David R. Spring | Kieron M. G. O'Connell | D. Spring | W. R. Galloway | D. R. Spring | W. Galloway
[1] David R Spring,et al. Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? , 2009, Expert opinion on drug discovery.
[2] Stuart L. Schreiber,et al. Gold(I)-Catalyzed Coupling Reactions for the Synthesis of Diverse Small Molecules Using the Build/Couple/Pair Strategy , 2009, Journal of the American Chemical Society.
[3] Andreas Bender,et al. Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.
[4] Suzanne Fergus,et al. Skeletal diversity construction via a branching synthetic strategy. , 2006, Chemical communications.
[5] Stephen J Haggarty,et al. The principle of complementarity: chemical versus biological space. , 2005, Current opinion in chemical biology.
[6] Stuart L. Schreiber,et al. Stereoselective Synthesis of over Two Million Compounds Having Structural Features Both Reminiscent of Natural Products and Compatible with Miniaturized Cell-Based Assays , 1998 .
[7] David R Spring,et al. Chemical genetics to chemical genomics: small molecules offer big insights. , 2005, Chemical Society reviews.
[8] Stuart L. Schreiber,et al. Skeletally Diverse Small Molecules Using a Build/Couple/Pair Strategy , 2009, Organic letters.
[9] Victoria Gilman,et al. HAND JIVE: Summer researchers—deaf and hearing—at James Madison put a twist on hands-on learning , 2004 .
[10] Martin Stahl,et al. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening. , 2003, Journal of medicinal chemistry.
[11] Stuart L. Schreiber,et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.
[12] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[13] Jared T. Shaw,et al. Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor. , 2007, Angewandte Chemie.
[14] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[15] Stuart L Schreiber,et al. Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.
[16] Stuart L Schreiber,et al. Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. , 2003, Journal of the American Chemical Society.
[17] A. Hopkins,et al. Navigating chemical space for biology and medicine , 2004, Nature.
[18] P. Bartlett,et al. Synthetic strategies in combinatorial chemistry. , 1997, Current opinion in chemical biology.
[19] David R Spring,et al. Gemmacin B: bringing diversity back into focus. , 2008, Organic & biomolecular chemistry.
[20] William Lewis,et al. Synthesis of natural-product-like scaffolds in unprecedented efficiency via a 12-fold branching pathway , 2011 .
[21] David R Spring,et al. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.
[22] David R Spring,et al. Diversity-oriented synthesis. , 2009, Chemical record.
[23] D. Young,et al. Accessing skeletal diversity using catalyst control: formation of n and n + 1 macrocyclic triazole rings. , 2009, Organic letters.
[24] Giovanni Muncipinto,et al. Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions. , 2006, Angewandte Chemie.
[25] David R Spring,et al. Exploiting domino enyne metathesis mechanisms for skeletal diversity generation. , 2008, Chemical communications.
[26] Wolfgang H. B. Sauer,et al. Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..
[27] Stuart L Schreiber,et al. Generating Diverse Skeletons of Small Molecules Combinatorially , 2003, Science.
[28] Stuart L. Schreiber,et al. Stereochemical and Skeletal Diversity Arising from Amino Propargylic Alcohols , 2010, Organic letters.
[29] Andreas Bender,et al. The discovery of antibacterial agents using diversity-oriented synthesis. , 2009, Chemical communications.
[30] J. Andrew Grant,et al. Small Molecule Shape-Fingerprints , 2005, J. Chem. Inf. Model..
[31] Craig W Lindsley,et al. Application of combinatorial chemistry science on modern drug discovery. , 2008, Journal of combinatorial chemistry.
[32] Alan L Harvey,et al. Natural products as a screening resource. , 2007, Current opinion in chemical biology.
[33] David R Spring,et al. Diversity-oriented synthesis; a challenge for synthetic chemists. , 2003, Organic & biomolecular chemistry.
[34] A. Bender,et al. Diversity-oriented synthesis of macrocyclic peptidomimetics , 2011, Proceedings of the National Academy of Sciences.
[35] Andreas Bender,et al. Anti-MRSA agent discovery using diversity-oriented synthesis. , 2008, Angewandte Chemie.
[36] J. Porco,et al. An approach to skeletal diversity using functional group pairing of multifunctional scaffolds. , 2007, Organic letters.
[37] S. Schreiber,et al. Pairwise use of complexity-generating reactions in diversity-oriented organic synthesis. , 2000, Organic letters.
[38] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[39] Tudor I. Oprea,et al. Chemography: the Art of Navigating in Chemical Space , 2000 .
[40] Stuart L. Schreiber,et al. Organic chemistry: Molecular diversity by design , 2009, Nature.
[41] Anang A Shelat,et al. Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.
[42] Derek S. Tan,et al. Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.
[43] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[44] David R Spring,et al. Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis. , 2008, Chemical communications.
[45] G. Schneider,et al. The State of the Art of Chemical Biology , 2009, Chembiochem : a European journal of chemical biology.
[46] Adam Nelson,et al. Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.
[47] Kieron M. G. O'Connell,et al. Diversity-oriented synthesis of bicyclic and tricyclic alkaloids. , 2010, Chemical communications.
[48] D. Seebach,et al. Alkylation of amino acids without loss of the optical activity: preparation of .alpha.-substituted proline derivatives. A case of self-reproduction of chirality , 1983 .
[49] Peter Schneider,et al. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. , 2003, Bioorganic & medicinal chemistry letters.
[50] Stuart L Schreiber,et al. Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.
[51] P. Hanson,et al. "Click, click, cyclize": a DOS approach to sultams utilizing vinyl sulfonamide linchpins. , 2009, Organic letters.
[52] P. Clemons,et al. Route to three-dimensional fragments using diversity-oriented synthesis , 2011, Proceedings of the National Academy of Sciences.
[53] B. Stockwell. Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.
[54] A. Bender,et al. Assessment of structural diversity in combinatorial synthesis. , 2005, Current opinion in chemical biology.
[55] Tudor I. Oprea,et al. Chemical space navigation in lead discovery. , 2002, Current opinion in chemical biology.
[56] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[57] Stu Borman. RESCUING COMBICHEM: Diversity-oriented synthesis aims to pick up where traditional combinatorial chemistry left off , 2004 .
[58] C. Dobson. Chemical space and biology , 2004, Nature.
[59] J. Vederas,et al. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.
[60] A. Mann,et al. 1,3-STEREOCONTROL WITH BROMOALLENES. SYNTHESIS OF N-BOC-ADDA, THE UNIQUE AMINO ACID PRESENT IN SEVERAL INHIBITORS OF SERINE/THREONINE PHOSPHATASES , 1996 .